Low and high affinity receptors mediate cellular uptake of heparanase

被引:23
作者
Ben-Zaken, Olga [1 ]
Shafat, Itay [1 ]
Gingis-Velitski, Svetlana [1 ]
Bangio, Haim [2 ]
Kelson, Idil Kasuto [2 ]
Alergand, Tal [2 ]
Amor, Yehudit [2 ]
Maya, Ruth Ben-Yakar [2 ]
Vlodavsky, Israel [1 ]
Ilan, Neta [1 ]
机构
[1] Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel
[2] Procognia Ltd, IL-77610 Ashdod, Israel
关键词
heparanase; glycosylation; lectin array; mannose; 6-phosphate; binding; receptor;
D O I
10.1016/j.biocel.2007.09.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heparanase is an endoglycosidase which cleaves heparan sulfate and hence participates in degradation and remodeling of the extracellular matrix. Importantly, heparanase activity correlated with the metastatic potential of tumor-derived cells, attributed to enhanced cell dissemination as a consequence of heparan sulfate cleavage and remodeling of the extracellular matrix barrier. Heparanase has been characterized as a glycoprotein, yet glycan biochemical analysis was not performed to date. Here, we applied the Qproteome (TM) GlycoArray kit to perform glycan analysis of heparanase, and compared the kit results with the more commonly used biochemical analyses. We employed fibroblasts isolated from patients with I-cell disease (mucolipidosis II), fibroblasts deficient of low density lipoprotein receptor-related protein and fibroblasts lacking mannose 6-phosphate receptor, to explore the role of mannose 6-phosphate in heparanase uptake. Iodinated heparanase has been utilized to calculate binding affinity. We provide evidence for hierarchy of binding to cellular receptors as a function of heparanase concentration. We report the existence of a high affinity, low abundant (i.e., low density lipoprotein receptor-related protein, mannose 6-phosphate receptor), as well as a low affinity, high abundant (i.e., heparan sulfate proteoglycan) receptors that mediate heparanase binding, and suggest that these receptors co-operate to establish high affinity binding sites for heparanase, thus maintaining extracellular retention of the enzyme tightly regulated. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:530 / 542
页数:13
相关论文
共 45 条
[1]   NONSELECTIVE AND EFFICIENT FLUORESCENT LABELING OF GLYCANS USING 2-AMINO BENZAMIDE AND ANTHRANILIC ACID [J].
BIGGE, JC ;
PATEL, TP ;
BRUCE, JA ;
GOULDING, PN ;
CHARLES, SM ;
PAREKH, RB .
ANALYTICAL BIOCHEMISTRY, 1995, 230 (02) :229-238
[2]   The urokinase/PAI-2 complex - A new high affinity ligand for the endocytosis receptor low density lipoprotein receptor-related protein [J].
Croucher, D ;
Saunders, DN ;
Ranson, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) :10206-10213
[3]   Heparanase, a potential regulator of cell-matrix interactions [J].
Dempsey, LA ;
Brunn, GJ ;
Platt, JL .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (08) :349-351
[4]   I-cell disease-like phenotype in mice deficient in mannose 6-phosphate receptors [J].
Dittmer, F ;
Hafner, A ;
Ulbrich, EJ ;
Moritz, JD ;
Schmidt, P ;
Schmahl, W ;
Pohlmann, R ;
Figura, KV .
TRANSGENIC RESEARCH, 1998, 7 (06) :473-483
[5]   Role of endothelial heparanase in delayed-type hypersensitivity [J].
Edovitsky, E ;
Lerner, I ;
Zcharia, E ;
Peretz, T ;
Vlodavsky, I ;
Elkin, M .
BLOOD, 2006, 107 (09) :3609-3616
[6]   Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis [J].
Edovitsky, E ;
Elkin, M ;
Zcharia, E ;
Peretz, T ;
Vlodavsky, I .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (16) :1219-1230
[7]   Heparanase as mediator of angiogenesis: mode of action [J].
Elkin, M ;
Ilan, N ;
Ishai-Michaeli, R ;
Friedmann, Y ;
Papo, O ;
Pecker, I ;
Vlodavsky, I .
FASEB JOURNAL, 2001, 15 (07) :1661-+
[8]   Cellular signaling by fibroblast growth factor receptors [J].
Eswarakumar, VP ;
Lax, I ;
Schlessinger, J .
CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (02) :139-149
[9]   The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation [J].
Ferro, V ;
Hammond, E ;
Fairweather, JK .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (06) :693-702
[10]  
FOLKMAN J, 1988, AM J PATHOL, V130, P393